Safety Profile of Medicines Used for the Treatment of Drug-Resistant Tuberculosis: A Descriptive Study Based on the WHO Database (VigiBase<sup>®</sup>)

Background: The introduction of new drugs that increase the usage of repurposed medicines for managing drug-resistant tuberculosis (DR-TB) comes with challenges of understanding, properly managing, and predicting adverse drug reactions (ADRs). In addition to the health consequences of ADRs for the i...

Full description

Bibliographic Details
Published in:Antibiotics
Main Authors: Alemayehu Lelisa Duga, Francesco Salvo, Alexander Kay, Albert Figueras
Format: Article
Language:English
Published: MDPI AG 2023-04-01
Subjects:
Online Access:https://www.mdpi.com/2079-6382/12/5/811